XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Mezzanine Equity
Common Stock
Additional Paid-In Capital
Accumulated Other- Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, value at Dec. 31, 2019 $ 63,459   $ 69 $ 127,553 $ (754) $ (63,409)
Beginning Balances, shares at Dec. 31, 2019     68,941      
Issuance of common stock from private placement 21,892   $ 1 21,891    
Issuance of common stock from private placement, shares     1,438      
Share-based expense 6,340     6,340    
Issuance of common stock pursuant to exercise of stock options - Cashless     $ 1 (1)    
Issuance of common stock pursuant to exercise of stock options - Cashless, shares     568      
Issuance of common stock pursuant to exercise of stock options - Cash 4,126   $ 1 4,125    
Issuance of common stock pursuant to exercise of stock options - Cash, shares     1,316      
Cash paid for taxes on restricted stock awards (657)     (115)   (542)
Foreign currency translation 551       551  
Short swing payment 91     91    
Net income 8,524     0   8,524
Ending Balance, value at Dec. 31, 2020 104,326   $ 72 159,884 (203) (55,427)
Ending Balance, shares at Dec. 31, 2020     72,263      
Issuance of common stock from private placement 67,769   $ 1 67,768    
Issuance of common stock from private placement, shares     1,134      
Share-based expense 36,475     36,475    
Issuance of common stock pursuant to exercise of stock options - Cashless 1   $ 1      
Issuance of common stock pursuant to exercise of stock options - Cashless, shares     540      
Issuance of common stock pursuant to exercise of stock options - Cash 3,720   $ 1 3,719    
Issuance of common stock pursuant to exercise of stock options - Cash, shares     972      
Foreign currency translation 817       817  
Net income 3,937     0 0 3,937
Ending Balance, value at Dec. 31, 2021 217,045   $ 75 267,846 614 (51,490)
Ending Balance, shares at Dec. 31, 2021     74,909      
Share-based expense 20,665     20,665    
Issuance of common stock pursuant to exercise of stock options - Cashless, shares     448      
Issuance of common stock pursuant to exercise of stock options - Cash 3,684   $ 1 3,683    
Issuance of common stock pursuant to exercise of stock options - Cash, shares     1,025      
Issuance of Series A convertible preferred shares - net of issuance costs (In Shares)   1,467        
Issuance of Series A convertible preferred shares - net of issuance costs   $ 824,488        
Dividends paid to Series A convertible preferred shares (11,526)     (11,526)    
Foreign currency translation (2,495)       (2,495)  
Net income (187,282)         (187,282)
Ending Balance, value at Dec. 31, 2022 $ 40,091   $ 76 $ 280,668 $ (1,881) $ (238,772)
Ending Balance, shares at Dec. 31, 2022     76,382      
Preferred Stock, Ending Balance at Dec. 31, 2022   1,467        
Preferred Stock Value Outstanding at Dec. 31, 2022   $ 824,488